Investigational serine/threonine kinase inhibitors against prostate cancer metastases.

about

Investigational serine/threonine kinase inhibitors against prostate cancer metastases.

Item

http://www.wikidata.org/entity/Q39021945

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Investigational serine/threonine kinase inhibitors against prostate cancer metastases.

@en

Investigational serine/threonine kinase inhibitors against prostate cancer metastases.

@nl

type

Item

label

Investigational serine/threonine kinase inhibitors against prostate cancer metastases.

@en

Investigational serine/threonine kinase inhibitors against prostate cancer metastases.

@nl

prefLabel

Investigational serine/threonine kinase inhibitors against prostate cancer metastases.

@en

Investigational serine/threonine kinase inhibitors against prostate cancer metastases.

@nl

P1476

Investigational serine/threonine kinase inhibitors against prostate cancer metastases.

@en

P2093

Claudio Festuccia

http://www.w3.org/2001/XMLSchema#string

P2860

Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7

CYP17 inhibitors in prostate cancer: latest evidence and clinical potential

Splice Variants of Androgen Receptor and Prostate Cancer

The dynamics of spatio-temporal Rho GTPase signaling: formation of signaling patterns

Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data.

Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities

The many faces of neuroendocrine differentiation in prostate cancer progression

Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08).

Novel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate Cancer

Cancer Stem Cells and Radioresistance: Rho/ROCK Pathway Plea Attention

P304

25-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13543784.2016.1266337

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27892725

http://www.w3.org/2001/XMLSchema#string